These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks

Even though the stock market has been going sideways this year, many IBD 50 stocks are extended from buy areas after making solid runs last year. That means investors have to look for secondary buy opportunities in these winners.

A few IBD 50 stocks have formed three-weeks-tight patterns or have found support at the 10-week moving average.

				    ↑
					X

This video file cannot be played.(Error Code: 102630)

								MarketSurge 2.0: Here's What To Expect From The New IBD Charting Platform
							

							

								See All Videos
							

						

					
					
						NOW PLAYING
						MarketSurge 2.0: Here's What To Expect From The New IBD Charting Platform

Both formations open opportunities to buy shares. But keep in mind that the market’s slog so far this year means investors need to carefully weigh adding new positions. IBD’s recommended market exposure is 40%-60%.

Axsome Therapeutics (AXSM) has been trading tightly for several weeks. Its pattern could be called a four-weeks-tight with a buy point at 191.50.

The company is due to report its fourth-quarter earnings Monday before the market opens. That could provide a new catalyst for the stock.

Analysts polled by FactSet expect the biotech, which is not yet profitable, to post a loss of 80 cents per share. Revenue is expected to climb 63% to $193.4 million.

IBD 50 Stocks To Watch

Axsome Therapeutics has made a 41% climb since it broke out of a cup-with-handle base in October. The company develops treatments for central nervous system conditions including depression, Alzheimer’s, migraines and narcolepsy.

Creditcorp (BAP) bounced off the 10-week moving average the past few days. Investors could use the 21-day exponential moving average — currently around 343 — as an acceptable entry. The stock has a 97 Composite Rating.

Peru’s largest financial institution pulled back to the 10-week line earlier this month. But it started to rebound after the fourth-quarter earnings report came out Feb. 13. Earnings jumped 41% as net interest income rose 5.8% and total deposits increased 5.3% year over year.

On Jan. 27, JPMorgan raised the price target to 412 from 310 and kept an overweight rating. Analysts cited a favorable macroeconomic backdrop and low credit penetration, TheFly.com reported. JPMorgan expects loan growth acceleration for Credicorp.

IBD Newsletters

Get exclusive IBD analysis and actionable news daily.

		SIGN UP NOW!

IBD Newsletters

Get exclusive IBD analysis and actionable news daily.

										*   							
								How To Invest								
								
							
						
										*   							
								Market Prep								
								
							
						
										*   							
								Tech Report								

Please enter a valid email address

Please select a newsletter

			GO

Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use

		x

Thank You!

You will now receive IBD Newsletters

			ALL DONE!

Something Went Wrong!

Please contact customer service

			CLOSE

Mining Stocks Rebound

The charts of mining stocks have become messy, but a couple of them are also finding support at the 10-week line.

Aris Mining (ARIS) has already made multiple pullbacks to the 10-week moving average. While normally that would mean the stock is too extended, Aris has been trading above 10 per share only since October.

Many institutional investors don’t pay attention to low-priced stocks because they typically lack much liquidity. In fact, Aris started trading on the NYSE on Feb. 19. The stock previously traded on the NYSE American exchange.

Aris stock is testing resistance around the 20 price level, so a move above it could be used as an entry. The stock has highest-possible 99 Composite and Relative Strength Ratings.

The company operates two underground gold mines in Colombia that produced a combined 257,000 ounces of gold in 2025.

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Equinox Gold (EQX) also found support at the 10-week line. However, this is at least the third test of the line since shares broke out of a base in August. Investors should wait for a new base to emerge. The mining company rallied 6% the past week after it reported fourth-quarter results on Thursday.

Several other IBD 50 stocks are forming bases or are in buy zones: Sterling Infrastructure (STRL), AnaptysBio (ANAB), Fabrinet (FN), Arcutis Biotherapeutics (ARQT), Harrow (HROW), SPX Technologies (SPXC), Napco Security (NSSC), Everus Construction Group (ECG) and Ubiquiti (UI).

Follow Kimberley Koenig for more stock market news on X, the platform formerly known as Twitter, @IBD_KKoenig.

**YOU MAY ALSO LIKE: **

Discover Profitable Trades Each Day With MarketDiem. See How.

What To Do When Growth Stocks Backtrack To Test Buy Points

Learn How To Time The Market With IBD’s ETF Market Strategy

Looking For Market Insights? Check Out Our Live Daily Segment | Stocks To Watch

Learn How To Buy Stocks | Stocks To Watch